Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕HDFC Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaHDFC
NAV₹591.2429₹15.6450
NAV date20 Nov 202620 Nov 2026
History20.6 years4.0 years
Expense ratio1.8%2.1%
Stars★★★★★★★★★★
Growth Score78.1049.20

Returns

Nippon India Pharma FundHDFC Business Cycle Fund
1 month+11.32%+7.59%
3 months+3.52%+1.66%
6 months+8.09%+11.28%
YTD+16.05%+6.77%
1 year+14.27%+4.91%
3 years (CAGR)+16.91%+10.77%
5 years (CAGR)+14.37%—
10 years (CAGR)+15.58%—
Since launch+17.64%+11.89%

Risk

Nippon India Pharma FundHDFC Business Cycle Fund
Volatility14.1%15.5%
Downside volatility9.1%10.5%
Sharpe0.740.28
Sortino1.150.41
Calmar1.140.56
Return / risk1.200.70
Deepest fall−47.36%−19.40%
Days to recover301234
Below its high+0.00%+0.00%

Against benchmark

Nippon India Pharma FundHDFC Business Cycle Fund
Alpha−2.75%−0.70%
Beta0.890.92
R²89.5%90.6%
Up capture83.5%92.4%
Down capture91.2%94.3%
Tracking error4.8%4.9%
Information ratio−0.88−0.23
Treynor0.110.04

Consistency

Nippon India Pharma FundHDFC Business Cycle Fund
Best 1-year+175.79%+38.26%
Middle 1-year+13.84%+5.55%
Worst 1-year−36.67%−7.13%
1-year periods with a loss23.4%14.6%
Middle 3-year+20.93%+11.45%
Positive months63.9%61.1%
Best day+3.40%+4.11%
Worst day−3.21%−6.25%
Worst 5% day−1.38%−1.53%
Positive days53.7%54.3%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundHDFC Business Cycle Fund
5-year XIRR+17.18%—
5-year value₹9,29,284—
3-year XIRR+13.26%+7.42%
1-year XIRR+21.05%+13.95%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth